Fds Intimate Whole Body Medicated Chafing Ointment
NDC Package 65197-730-15

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Fds Intimate Whole Body Medicated Chafing ointment is apply as needed. This formulation utilizes a ointment delivery system. Marketed by Wellspring Pharmaceutical Corporation, this product is identified by NDC 65197-730 and is authorized under FDA application M016.

Identification & Billing

NDC Package Code
65197-730-15
Package Description
1 TUBE in 1 BOX / 42.5 g in 1 TUBE
Product Code
65197-730
11-Digit Billing Format
65197073015
RxNorm Crosswalk
  • RxCUI: 664981 - lanolin 15.5 % / petrolatum 53.4 % Topical Ointment
  • RxCUI: 664981 - lanolin 0.155 MG/MG / petrolatum 0.534 MG/MG Topical Ointment
  • RxCUI: 664981 - lanolin 15.5 GM per 100 GM / petrolatum 53.4 GM per 100 GM Topical Ointment

Clinical Specifications

Proprietary Name
Fds Intimate Whole Body Medicated Chafing
Non-Proprietary Name
Fds Intimate Whole Body Medicated Chafing
Substance Name
Lanolin; Petrolatum
Dosage Form
Ointment - A semisolid3 dosage form, usually containing <20% water and volatiles5 and >50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Usage Information
apply as needed

Regulatory & Marketing

Labeler Name
Wellspring Pharmaceutical Corporation
Product Type
Human Otc Drug
FDA Application #
M016
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-31-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 65197-730-15 identifies a specific commercial package of 1 tube in 1 box / 42.5 g in 1 tube of Fds Intimate Whole Body Medicated Chafing, a human over the counter drug labeled by Wellspring Pharmaceutical Corporation. This ointment is formulated for topical use and contains lanolin; petrolatum as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Wellspring Pharmaceutical Corporation on January 31, 2025. The current certification is valid through December 31, 2026.

How is this Wellspring Pharmaceutical Corporation product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 65197073015. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
65197-730-15
11-Digit CMS (5-4-2)
65197-0730-15

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.